Galaxy Medicare Limited

GML NSE Healthcare Medical Equipment & Supplies

Strengths

  • Low debt: debt-to-equity of 0.1.
  • Comfortable interest cover: operating profit covers interest about 15.1 times.
  • Return on equity is moderate at 10.6%.
  • Return on capital employed is moderate at 13.6%.
  • Net profit margin is 8.6%.
  • Profit has compounded about 35% a year over five years.
  • Pays a dividend (yield about 4.14%).
  • Promoters hold a majority stake (72.98%).

!Watch-points

  • Recent profit growth (4%) is slower than the five-year pace (35%).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreGrey zone
2.15

This middle range was less conclusive in Altman’s study — neither clearly safe nor clearly distressed.

Computed without the working-capital term (current-asset split not available for this stock).

Piotroski F-ScoreWeak
3 / 7

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 7 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap₹ 26 Cr
Current Price
High / Low₹ 54.00 / 15.20
Stock P/E7.50
Book Value₹ 26.60
Dividend Yield4.14%
ROCE13.60%
ROE10.60%
Face Value₹ 10.00
Debt to Equity0.10
PEG Ratio0.13
EV / EBITDA6.23
Industry PE37.70
P/B Ratio0.63
EPS₹ 2.25
Debt₹ 4 Cr
PAT Margin8.55%
Cash PAT₹ 4 Cr
ICR15.11
Promoter Holding72.98%
FII Holding
DII Holding0.00%
Public Holding27.02%

Note on calculated ratios: where a value is not published in the source data, we compute it from the reported financials — Debt to Equity = total borrowings ÷ (equity capital + reserves); EV / EBITDA = (market cap + debt − cash) ÷ (operating profit + depreciation); PEG = P/E ÷ 3-year profit growth %. These may differ slightly from other sources that use different periods or TTM figures. Current Price, Market Cap and P/E reflect the live quote (cached 15 min).

Compounded Sales Growth
10 Years
5 Years 7.00%
3 Years 9.00%
TTM 3.00%
Compounded Profit Growth
10 Years
5 Years 35.00%
3 Years 58.00%
TTM 4.00%
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years 14.00%
Last Year 11.00%
Educational data only. Not a recommendation to buy, sell or hold any security.